COVID-19 has scrambled MCO cost management.
F. Randy Vogenberg, PhD
Advertisement
Articles by F. Randy Vogenberg, PhD
Advertisement
Latest Updated Articles
COVID-19, MCOs, Market Change, and UncertaintyPublished: April 7th 2020 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
The FDA proposes ditching comparative efficacy studies for biosimilars
2
UC Davis develops new drug for bladder cancer patients
3
Misdiagnosis of Type 1 diabetes remains a major problem, despite advances
4
Atopic dermatitis care advances in 2025 with new biologics, topicals and oral therapies
5